Myofacial Pain and TMJ Disorders Botox Treatment with Oldness Affection

Authors

  • Zina Ali Daily B.D.S,M.Sc.(Periodontic) Assistant Lecturer, College of Dentistry, University of Al-Ameed, Iraq-Karbala Author
  • Nawres Bahaa Mohammed B.D.S,C.A.B.M.S(Oral and maxillofacial surgery) Assistant professor, College of dentistry, University of Al-Ameed, Iraq — Karbala. Author
  • Muntathar Muhsen Abusanna B.D.S,C.A.B.M.S(Oral and maxillofacial surgery) Assistant professor, University of Al-Ameed, College of dentistry. University of Al-Ameed, Iraq — Karbala. Author
  • Ban zuhair Ahmed Department of periodontogy, Al-ESRAA university college, Baghdad, Iraq Author

Keywords:

Myofascial Discomfort, Arthritis, Oldness, Botulinum Toxin, TMJ Problems.

Abstract

TMJD is a disorder caused by masticatory myoarthropathy, which can be treated with botulinum toxin injections. This study aims to determine the effects of BTX-A injections on joint click, pain intensity, deviation on opening and maximum mouth opening.  Male and female patients between the ages of 16 and 42 were included in the human sample, all of whom were experiencing myofacial discomfort, trismus, and TMJ noises due to temporomandibular joint dysfunction. Individuals receiving 100 U of botulinum toxin type A (BTX-A) injected at 100 mL per temporalis, lateral pterygoid and masseter muscle were enrolled in the trial. Each individual was randomly allocated to one of four groups.: 7 individuals, both male and female, aged 16-22, made up Group I. Patients aged 23-29 made up Group II, which also included 7 men. 7 individuals between the ages of 30 and 36 made up Group III. Group IV had 7 patients (aged 37-43) of both sexes experiencing myofacial discomfort due to temporomandibular joint dysfunction.  This study evaluated damage to the teeth and gums from clenching and grinding, also known as bruxism or parafunction. Four key TMD symptoms were reported both before and after a BTX-A injection: pain level, maximum mouth opening, deviation on opening and joint click. Clinical effectiveness and safety were assessed ten days, 30 days, and 3 months following injection. Results showed that older patients in Group IV (older age) reported the highest mean and SD values for pain intensity, maximum mouth opening, joint click, and deviation on opening. Group III finished in second place, followed by Groups II and I. (younger age). Maximal mouth opening, joint click, and opening deviation all showed improvement in HS between the first (pre-treatment visit) and subsequent visits following BTX-A injection. 

Downloads

Download data is not yet available.

References

Alexis K., Helios B. and Pierre C. et al. Assessing the

effectiveness of botulinum toxin injections into

masticatory muscles in the treatment of

temporomandibular disorders. Original Article.J Oral

Med Oral Surg 2018;24:107-111.

https://doi.org/10.1051/mbcb/2018001)

Niv M.( Christropher T. and Andrew B.

Temporomandibular Myofacial Pain Treated with

Botulinum Toxin Injection. Journal Toxins 2015,7,2791-

;doi:10.3390/toxins7082791.

www.mdpi.com/journal/toxins

Shilpa P.S., Kaul R., Sultana N. and Bhat S. Botulinum

toxin: The Midas touch. J. Nat. Sci. Biol. Med. 2014;5:8-

doi:10.4103/0976-9668.127274.

Khosla S. etal. Bisphosphonate-Associated Osteonecrosis

of the Jaw: Report of a TaskForce of the American

Society for Bone and Mineral Research. Journal of bone

and Mineral Research2OO7; 22:10.

Lagalla G., Millevolte M., Capecci M., Provinciali L.and

Ceravolo, M.G. Botulinum toxin type a for drooling in

Parkinson's disease: A double-blind, randomized,

placebo-controlled study.J. Mov. Disord 2006; 21: 704-

Hyun-Suk K., Pil-Young Y., and Young-Kyun K. A clinical

evaluation of botulinum toxin-A injections in the

temporomandibular disorder treatment.Maxillofac Plast

Reconstr Surg. 2016 Dec; 38(1): 5 .Published online 2016

Jan 28. doi: 10.1186/s40902-016-0051-7.

Deepak G., Soheyl S. Shambulingappa P., Ravinder S., and

Amit A. Correlation of Condylar Translation During

Maximal Mouth Opening with Presence of Signs of

Temporomandibular Joint Disorders in an

Asymptomatic Population of 18-25 Years Age Group of

Northern India.Open Dent J. 2018;12: 770-781. Published

online 2018 Sep 28.

doi:10.2174/1745017901814010770

Ravleen N., Deepa J., Shashikant S. Botulinum toxin in the

management of head and neck disorders.J. ORAL AND

MAXILLOFACIAL SURGERY 2017 April ;123: 4.

Meunier FA, Schiavo G, Molgo J. Botulinum neurotoxins:

from paralysis to recovery of functional neuromuscular

transmission. J Physiol Paris. 2002;96:105-13.

doi:10.1016/S0928-4257(01)00086-9

Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum

toxin type A induces direct analgesic effects in chronic

neuropathic pain. Ann Neurol. 2008;64:274-84. doi:

1002/ana.21427.

Dressier D, Adib Saberi F. Botulinum toxin: mechanisms

of action. Eur Neurol. 2005;53:3-9. doi:

O.1159/OOOO83259.

Molgorzoto P., Ewa F., Michal S., Katarzyna K., and

Mieszko W .The efficiency of botulinum toxin type A for

the treatment of masseter muscle pain in patients with

temporomandibular joint dysfunction and tension-type

headache.J Headache Pain 2017; 18(1): 38 .Published

online 2017 Mar 21. doi:10.1186/s10194-017-0744-z

Ronald S. P., Mark P. M., and Pamela J. Y.Communication

Breakdown: The Impact of Ageing on Synapse

Structure.Ageing Res Rev.J. HHS Author Manuscripts

Mar; 14: 31-42. PMC4094371. Published online 2014

Feb 2. doi: 10.1016/j.arr.2014.01.003

Peters A., Sethares C., Luebke J.Synapses are lost during

aging in the primate prefrontal cortex. J.Neuroscience

Apr 9;152(4):970-81.

Beramendi A., Peron S., Casanova G., Reggiani C„

Cantera R. Neuromuscular junction in abdominal

muscles of Drosophila melanogaster during adulthood

and aging.J Comp Neurol 2007 Apr 1; 501(4):498-508.

Patrick N. S., Donald T. K., and William E. G.Muscle

Changes in Aging Understanding Sarcopenia.J. Sports

Health 2014 Jan; 6(1): 36-40 .PMC3874224

.doi: 10.1177/1941738113502296.

Karsten K., and Martin E.Strength and muscle mass loss

with aging process. Age and strength loss. Muscles

Ligaments Tendons J. 2013 Oct-Dec; 3(4): 346-350.

PMC3940510

Jing L,Ying-Ying X., Qi-Lin Z., and Wei-Feng L.CIinical

StudyEfficacy and Safety of Botulinum Toxin Type A in

Treating Patients of Advanced Age with Idiopathic

Trigeminal Neuralgia.J. Hindawi Pain Research and

Management. Volume 2018, Article ID 7365148, 5 pages.

https://doi.org/10.1155/2018/7365148

H. Zhang, Y. Lian, Y. Ma et al., "Two doses of botulinum toxin type a for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial," Journal of Headache and Pain2014;15: 1,p. 65

Downloads

Published

2023-04-30

Issue

Section

Articles

How to Cite

Ali Daily, Z., Bahaa Mohammed, N., Muhsen Abusanna, M., & zuhair Ahmed, B. (2023). Myofacial Pain and TMJ Disorders Botox Treatment with Oldness Affection. History of Medicine, 9(2). https://historymedjournal.com/HOM/index.php/medicine/article/view/529